Literature DB >> 16966712

Impaired portal circulation resulting from L-arginine deficiency in patients with lysinuric protein intolerance.

T Takeda, H Watanabe, T Saito, K Saito, H Takeda, H Togashi, J Fujii, Y Takasago, S Kawata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16966712      PMCID： PMC1856429          DOI： 10.1136/gut.2005.086603

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

1.  A cluster of lysinuric protein intolerance (LPI) patients in a northern part of Iwate, Japan due to a founder effect. The Mass Screening Group.

Authors:  A Koizumi; Y Shoji; J Nozaki; A Noguchi; X E; M Dakeishi; T Ohura; K Tsuyoshi; W Yasuhiko; M Manabe; Y Takasago; G Takada
Journal:  Hum Mutat       Date:  2000-09       Impact factor: 4.878

2.  Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin.

Authors:  R G Kilbourn; P Belloni
Journal:  J Natl Cancer Inst       Date:  1990-05-02       Impact factor: 13.506

3.  SLC7A7 genomic structure and novel variants in three Japanese lysinuric protein intolerance families.

Authors:  A Noguchi; Y Shoji; A Koizumi; T Takahashi; M Matsumori; T Kayo; T Ohata; Y Wada; I Yoshimura; S Maisawa; M Konishi; Y Takasago; G Takada
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

4.  Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study.

Authors:  F Piscaglia; G Zironi; S Gaiani; A Mazziotti; A Cavallari; L Gramantieri; M Valgimigli; L Bolondi
Journal:  Hepatology       Date:  1999-07       Impact factor: 17.425

5.  Vascular endothelial dysfunction resulting from L-arginine deficiency in a patient with lysinuric protein intolerance.

Authors:  Y Kamada; H Nagaretani; S Tamura; T Ohama; T Maruyama; H Hiraoka; S Yamashita; A Yamada; S Kiso; Y Inui; N Ito; Y Kayanoki; S Kawata; Y Matsuzawa
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

6.  Identification of arginine as a precursor of endothelium-derived relaxing factor.

Authors:  I Sakuma; D J Stuehr; S S Gross; C Nathan; R Levi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

8.  Flow-induced release of endothelium-derived relaxing factor.

Authors:  G M Rubanyi; J C Romero; P M Vanhoutte
Journal:  Am J Physiol       Date:  1986-06

9.  Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure.

Authors:  P Taourel; P Blanc; M Dauzat; M Chabre; J Pradel; B Gallix; D Larrey; J M Bruel
Journal:  Hepatology       Date:  1998-10       Impact factor: 17.425
  9 in total
  2 in total

Review 1.  Overview of symptoms and treatment for lysinuric protein intolerance.

Authors:  Atsuko Noguchi; Tsutomu Takahashi
Journal:  J Hum Genet       Date:  2019-06-18       Impact factor: 3.172

2.  Lysinuric protein intolerance in a family of Mexican ancestry with a novel SLC7A7 gene deletion. Case report and review of the literature.

Authors:  David Carpentieri; Margaret F Barnhart; Kyrieckos Aleck; Tamir Miloh; Daphne deMello
Journal:  Mol Genet Metab Rep       Date:  2015-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.